Tong Ren Tang Launches IPO with Bai Hui Serving as Joint Bookrunner and Joint Lead Arranger

(Source: Straits Consumer News)

Reprinted from: Straits Consumer News

Beijing Tongrentang Medical and Elderly Care Investment Co., Ltd. (hereinafter referred to as “Tongrentang Medical and Elderly Care”), stock code 2667.HK, officially launched its public offering from March 20 to March 25, 2026. Baohui Capital team served as co-bookrunner and co-lead manager for this IPO project.

According to Baohui Capital, this IPO plans to issue approximately 105 million H-shares globally, with an offering price range of HKD 7.30 to HKD 8.30 per share, aiming to raise a maximum net amount of about HKD 900 million. The company is expected to be listed on the Main Board of the Hong Kong Stock Exchange on March 30, 2026.

According to the prospectus, Tongrentang Medical and Elderly Care is a flagship platform under the century-old brand “Tongrentang,” focusing on integrated traditional Chinese medicine (TCM) medical and elderly care services. The company has established a “three-in-one” layout of medical care, elderly care, and health products, with core models including:

Traditional Chinese Medicine Medical Services: Operating multiple TCM hospitals and chain clinics, with a focus on Beijing-Tianjin-Hebei and Yangtze River Delta regions.

Medical and Elderly Care Management Services: Providing strategic planning and guidance for medical-related institutions, improving their internal operations and control systems.

Health Products: Selling Tongrentang-branded and self-developed Chinese health products, including main products such as An Gong Niu Huang Wan (natural) and Niu Huang Qing Xin Wan, among others.

Based on the total revenue from TCM medical services in 2024, Tongrentang Medical and Elderly Care ranks second in the non-public TCM hospital medical service industry with a 0.2% market share. Leveraging over 350 years of brand heritage, Tongrentang Medical and Elderly Care has become one of China’s largest private TCM medical and elderly care service groups, establishing high-standard TCM talent teams and chain operation systems.

During the listing process, Baohui Capital team actively participated as co-bookrunner and co-lead manager. With deep insights into the healthcare sector and extensive cross-border capital market experience, Baohui Capital helped Tongrentang Medical and Elderly Care connect precisely with international investors, ensuring smooth project progress.

Important Notice: The above content is provided by Baohui Capital for reference only and does not replace investors’ judgment and decision-making. Investors should analyze and evaluate based on their own risk tolerance and needs to develop the most suitable investment strategy.

Baohui Capital’s subsidiary, Baohui Securities (Central Registration No.: BPQ161), is licensed by the Hong Kong Securities and Futures Commission to conduct Type 1 and Type 4 regulated activities. Additionally, its subsidiary Baohui Capital (Central Registration No.: BSM550) holds licenses for Type 1 and Type 6 activities and has sponsor qualification.

Massive information, precise analysis, all on Sina Finance APP.